- The Children's Place, Inc.’s (NASDAQ:PLCE) shares tanked 10.3% after the company reported fourth quarter 2018 earnings per share of $1.10, lower than the Zacks Consensus Estimate of $2.11 a share
- Biogen Inc.’s (NASDAQ:BIIB) shares declined 2.1% after the company announced that it had agreed to purchase Nightstar Therapeutics plc (NASDAQ:NITE) for $25.50 a share
- Shares of Ascendis Pharma A/S (NASDAQ:ASND) rallied 74% after the company announced that its TransCon Growth Hormone trial had achieved the desired primary end result
- Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) , rose 5.2% after the company announced that it had entered into a partnership with Lupus Therapeutic Partners to start Phase 1 trial for lupus treatment
Ascendis Pharma A/S (ASND): Free Stock Analysis Report
Biogen Inc. (BIIB): Free Stock Analysis Report
Children's Place, Inc. (The) (PLCE): Free Stock Analysis Report
Nightstar Therapeutics PLC Sponsored ADR (NITE): Free Stock Analysis Report
Takeda Pharmaceutical Co. (TAK): Free Stock Analysis Report
Original post
Zacks Investment Research